عنوان

Addressing the barriers to pediatric drug development :

شابک

0309107431

شابک

1281800236

شابک

9780309107433

شابک

9781281800237

شابک اشتباه

0309107423

شابک اشتباه

9780309107426

شماره

b708213

عنوان اصلي

Addressing the barriers to pediatric drug development :

نام عام مواد

[Book]

ساير اطلاعات عنواني

workshop summary /

نام نخستين پديدآور

Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

محل نشرو پخش و غیره

Washington, D.C. :

نام ناشر، پخش کننده و غيره

National Academies Press,

تاریخ نشرو بخش و غیره

©2008.

نام خاص و کميت اثر

1 online resource (xii, 52 pages)

متن يادداشت

Includes bibliographical references.

متن يادداشت

Introduction -- Response to drugs in various age groups -- Product labeling -- Organization of this summary -- Regulatory framework -- Best pharmaceuticals for children act -- Pediatric Research Equity Act -- Impact of pediatric drug legislation -- Discussion -- Current challenges in developing and prescribing drugs for children -- Barriers to pediatric drug development -- Formulations -- Dosing, bioavailability, and drug response -- Models for enhancing pediatric drug development -- Vaccine development in the United States -- The European Union's new regulatory approach -- The St. Jude's model for pediatric oncology drugs -- Challenges and opportunities for the future -- Systemic solutions -- Elimination of economic barriers -- Concluding thoughts.

بدون عنوان

0

متن يادداشت

Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.

عنوان

Addressing the barriers to pediatric drug development.

شماره استاندارد بين المللي کتاب و موسيقي

9780309107426

موضوع مستند نشده

Drug development.

موضوع مستند نشده

Drugs-- Testing-- Law and legislation-- United States.

موضوع مستند نشده

Pediatric pharmacology-- Law and legislation-- United States.

موضوع مستند نشده

Pediatric pharmacology-- Research-- United States.

موضوع مستند نشده

Age Factors.

موضوع مستند نشده

Child.

موضوع مستند نشده

Clinical Trials as Topic-- standards.

موضوع مستند نشده

Drug Design.

موضوع مستند نشده

Drugs, Evaluation-- standards.

موضوع مستند نشده

Pediatrics-- United States, Congresses.

موضوع مستند نشده

Drug development.

موضوع مستند نشده

Drugs-- Testing-- Law and legislation.

موضوع مستند نشده

MEDICAL-- Chemotherapy.

موضوع مستند نشده

United States.

بدون عنوان

7

موضوع مستند نشده

M

موضوع مستند نشده

MED-- 012000

شماره

ويراست

شماره رده

نشانه اثر

شماره رده

شماره رده

نشانه اثر

مستند نام اشخاص تاييد نشده

Butler, Adrienne Stith.

مستند نام اشخاص تاييد نشده

Knutsen, Andrea.

مستند نام اشخاص تاييد نشده

Vanchieri, Cori.

مستند نام تنالگان تاييد نشده

Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation.

تاريخ عمليات

20201207231156.0

قواعد فهرست نويسي ( بخش توصيفي )

pn

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y